BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 70 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $44,000 | -95.1% | 42,007 | -42.1% | 0.02% | -50.0% |
| Q1 2017 | $895,000 | +24.3% | 72,500 | -5.9% | 0.05% | +33.3% |
| Q1 2016 | $720,000 | -58.7% | 77,020 | -35.9% | 0.04% | -50.0% |
| Q3 2015 | $1,745,000 | -66.0% | 120,094 | -50.2% | 0.07% | -61.5% |
| Q2 2015 | $5,127,000 | -4.4% | 241,039 | +4.1% | 0.19% | -16.1% |
| Q1 2015 | $5,364,000 | -29.8% | 231,515 | -30.2% | 0.22% | -7.5% |
| Q4 2014 | $7,638,000 | – | 331,515 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
| X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
| Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
| Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
| ARK Investment Management | 417,433 | $538,000 | 0.01% |
| ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |